Table 4.
The relation between the expression of MMP-2 and clinic-pathological factors
| Pathologic parameter | Cases(N) | MMP2 expression positive rate % | χ2 | P value |
|---|---|---|---|---|
| Male |
27 |
63.0 (17/27) |
0.065 |
0.799 |
| Female |
18 |
66.7 (12/18) |
||
| Age < 60 |
19 |
73.7 (14/19) |
1.225 |
0.268 |
| Age ≥60 |
26 |
57.7 (15/26) |
||
| Located in head |
37 |
67.6 (25/37) |
0.886 |
0.642 |
| Located in tail |
6 |
50 (3/6) |
||
| Whole pancreas cancer |
2 |
50 (1/2) |
||
| Size of primary carcinoma(<3 cm) |
30 |
73.3 (22/30) |
3.103 |
0.978 |
| Size of primary carcinoma(≥3 cm) |
15 |
46.7 (7/15) |
||
| Histodifferentiation(II) |
26 |
84.6 (22/26) |
11.109 |
0.004* |
| Histodifferentiation(III) |
7 |
43.9 (3/7) |
||
| Histodifferentiation(IV) |
12 |
33.3 (4/12) |
||
| Lymph nodes metastasis Negative |
20 |
35 (7/20) |
13.621 |
0.000* |
| Lymph nodes metastasis Positive |
25 |
88 (22/25) |
||
| pTNM stage I |
9 |
22.2 (2/9) |
23.377 | 0.000* |
| pTNM stage II |
11 |
45.5 (5/11) |
||
| pTNM stage III |
12 |
75 (9/12) |
||
| pTNM stage IV |
13 |
100 (13/13) |
||
| Normal tissue | 27 | 0 (0/27) |
*P < 0.01.